Clinical pharmacology and toxicology of dichloroacetate.
P W Stacpoole
G N Henderson
Z Yan
M O James
Abstract
Dichloroacetate (DCA) is a xenobiotic of interest to both environmental toxicologists and clinicians. The chemical is a product of water chlorination and of the metabolism of various drugs and industrial chemicals. Its accumulation in groundwater and at certain Superfund sites is considered a potential health hazard. However, concern about DCA toxicity is predicated mainly on data obtained in inbred rodent strains administered DCA at doses thousands of times higher than those to which humans are usually exposed. In these animals, chronic administration of DCA induces hepatotoxicity and neoplasia. Ironically, the DCA doses used in animal toxicology experiments are very similar to those used clinically for the chronic or acute treatment of several acquired or hereditary metabolic or cardiovascular diseases. As a medicinal, DCA is generally well tolerated and stimulates the activity of the mitochondrial pyruvate dehydrogenase enzyme complex, resulting in increased oxidation of glucose and lactate and an amelioration of lactic acidosis. By this mechanism, the drug may also enhance cellular energy metabolism. DCA is dehalogenated in vivo to monochloroacetate and glyoxylate, from which it can be further catabolized to glycolate, glycine, oxalate, and carbon dioxide. It remains to be determined whether important differences in its metabolism and toxicology exist in humans between environmentally and clinically relevant doses.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bersin R. M., Stacpoole P. W. Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J. 1997 Nov;134(5 Pt 1):841–855. doi: 10.1016/s0002-8703(97)80007-5. [DOI] [PubMed] [Google Scholar]
- Curry S. H., Chu P. I., Baumgartner T. G., Stacpoole P. W. Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin Pharmacol Ther. 1985 Jan;37(1):89–93. doi: 10.1038/clpt.1985.17. [DOI] [PubMed] [Google Scholar]
- Curry S. H., Lorenz A., Chu P. I., Limacher M., Stacpoole P. W. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Biopharm Drug Dispos. 1991 Jul;12(5):375–390. doi: 10.1002/bdd.2510120507. [DOI] [PubMed] [Google Scholar]
- Harrison P. C., Mainolfi E., Madwed J. B. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation. J Heart Lung Transplant. 1998 Feb;17(2):150–157. [PubMed] [Google Scholar]
- Henderson G. N., Yan Z., James M. O., Davydova N., Stacpoole P. W. Kinetics and metabolism of chloral hydrate in children: identification of dichloroacetate as a metabolite. Biochem Biophys Res Commun. 1997 Jun 27;235(3):695–698. doi: 10.1006/bbrc.1997.6868. [DOI] [PubMed] [Google Scholar]
- Mughal F. H. Chlorination of drinking water and cancer: a review. J Environ Pathol Toxicol Oncol. 1992 Sep-Oct;11(5-6):287–292. [PubMed] [Google Scholar]
- Stacpoole P. W., Barnes C. L., Hurbanis M. D., Cannon S. L., Kerr D. S. Treatment of congenital lactic acidosis with dichloroacetate. Arch Dis Child. 1997 Dec;77(6):535–541. doi: 10.1136/adc.77.6.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stacpoole P. W., Harman E. M., Curry S. H., Baumgartner T. G., Misbin R. I. Treatment of lactic acidosis with dichloroacetate. N Engl J Med. 1983 Aug 18;309(7):390–396. doi: 10.1056/NEJM198308183090702. [DOI] [PubMed] [Google Scholar]
- Stacpoole P. W., Moore G. W., Kornhauser D. M. Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia. N Engl J Med. 1978 Mar 9;298(10):526–530. doi: 10.1056/NEJM197803092981002. [DOI] [PubMed] [Google Scholar]
- Stacpoole P. W. The pharmacology of dichloroacetate. Metabolism. 1989 Nov;38(11):1124–1144. doi: 10.1016/0026-0495(89)90051-6. [DOI] [PubMed] [Google Scholar]
- Stacpoole P. W., Wright E. C., Baumgartner T. G., Bersin R. M., Buchalter S., Curry S. H., Duncan C. A., Harman E. M., Henderson G. N., Jenkinson S. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med. 1992 Nov 26;327(22):1564–1569. doi: 10.1056/NEJM199211263272204. [DOI] [PubMed] [Google Scholar]